2012
DOI: 10.1186/1465-9921-13-1
|View full text |Cite
|
Sign up to set email alerts
|

Endothelial-monocyte activating polypeptide II disrupts alveolar epithelial type II to type I cell transdifferentiation

Abstract: BackgroundDistal alveolar morphogenesis is marked by differentiation of alveolar type (AT)-II to AT-I cells that give rise to the primary site of gas exchange, the alveolar/vascular interface. Endothelial-Monocyte Activating Polypeptide (EMAP) II, an endogenous protein with anti-angiogenic properties, profoundly disrupts distal lung neovascularization and alveolar formation during lung morphogenesis, and is robustly expressed in the dysplastic alveolar regions of infants with Bronchopulmonary dysplasia. Determ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
31
1
2

Year Published

2013
2013
2022
2022

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 45 publications
(35 citation statements)
references
References 46 publications
1
31
1
2
Order By: Relevance
“…Epidemiological data indicate these two conditions are linked; obese individuals are at greater risk for asthma development, increased severity, symptoms, treatment resistance and reduced quality of life (QOL) than non-obese individuals (24). Nearly 20% of obese adolescents have asthma, compared to 14.2% of non-obese adolescents (5).…”
Section: Introductionmentioning
confidence: 99%
“…Epidemiological data indicate these two conditions are linked; obese individuals are at greater risk for asthma development, increased severity, symptoms, treatment resistance and reduced quality of life (QOL) than non-obese individuals (24). Nearly 20% of obese adolescents have asthma, compared to 14.2% of non-obese adolescents (5).…”
Section: Introductionmentioning
confidence: 99%
“…Because of the close proximity of the developing airways and vasculature in the lung, vascular mediators have been suggested to influence pulmonary development. For instance, Chen and colleagues (2) and Schwarz and colleagues (3)(4)(5) used a mouse fetal lung allograft model to show that endothelial-monocyte activating polypeptide II can not only inhibit neovascularization, but can also significantly impair epithelial morphogenesis. Based on these and similar findings, our laboratory has focused on the role of vascular mediators during pulmonary development.…”
mentioning
confidence: 99%
“…AEC II can proliferate into new AEC II and transdifferentiate into AEC I (1, 24). Following lung injury, AEC II-to-AEC I transdifferentiation is an important mechanism in injury repair (16,24,39). Tight junctions between epithelial cells regulate diffusion of solutes through the paracellular pathway (47, 61).…”
mentioning
confidence: 99%